Skip to main content

Patients' views on improving sickle cell disease management in primary care

Sickle cell disease (SCD) is the most common and fastest growing genetic disorder in England. SCD is an illness in which recurrent pain, also referred to as vaso-occlusive crisis, is a chronic concern. Primary care professionals therefore play a key role during the initial presentation of symptoms, as well as the management of long-term complications including such recurrent pain. In England, London residents account for approximately three quarters of all SCD admissions to hospitals, with the London Borough of Brent being one of the highest risk areas for SCD. Many aspects of SCD can be effectively and efficiently managed in primary care. Previous studies have shown successful interventions that move management of SCD, particularly uncomplicated sickle cell pain episodes, from tertiary towards primary care.

Focus groups may be useful for obtaining developmental input in managing SCD in primary care. In a paper published recently in JRSM Short Reports, Ghida AlJuburi and colleagues reported the findings of a focus group study held at the Sickle Cell Society in the London Borough of Brent. They aimed to identify patient and carer perspectives of general practitioner (GP) knowledge and treatment of SCD, and to identify areas in which improvements could be made. This information helped to design an educational intervention which could help further engage primary health-care professionals in the care and management of their sickle cell patients. The study was part of a wider service improvement programme to improve the management of SCD in the London Borough of Brent.

The study identified a number of barriers to patients with SCD and their carers engaging fully with primary care services. These ranged from practical difficulties accessing services when required, poor communication between primary and secondary care professionals and a perceived lack of confidence in the ability of primary care professionals to provide chronic disease management specific to SCD. This study highlighted that SCD patients and carers have many criticisms about the current quality of services for managing patients with SCD in primary care. The study also helped provide key themes and useful suggestions that have been used to develop an educational intervention for general practices that will be used to improve SCD management in primary care.

Comments

Popular posts from this blog

Improving discharge planning in NHS hospitals

Factors that need to be considered in discharge planning that have been identified in previous projects include:

Ensuring that discharge arrangements are discussed with patients, family members and carers; and that they are given a copy of the discharge summary.Adequate coordination between the hospital, community health services, general practices, and the providers of social care services.There is a follow-up after discharge of patients at high risk of complications or readmission - either in person or by telephone - to ensure that the discharge arrangements are working well. Medicines reconciliation is carried out. This is the process of verifying patient medication lists at a point-of-care transition, such as hospital discharge, to identify which medications have been added, discontinued, or changed from pre-admission medication lists.Ensuring that any outstanding test results at discharge are obtained and passed on to primary care teams; and ensuring there are clear arrangements …

What will Brexit mean for the NHS?

On the 29 March 2017, the Prime Minister of the UK Theresa May, formally notified the European Union (EU) Council President, Donald Tusk, of the UK’s intention to leave the EU. Theresa May’s letter to Donald Tusk triggers a two-year process during which the UK will have to negotiate both the terms of its exit from EU and the arrangements that will replace those we have had for over 40 years with the other member states of the EU. The consequences of the United Kingdom’s departure from the EU (commonly referred to as ‘Brexit’) will be wide-ranging and will affect all areas of UK’s society, including the National Health Service (NHS).

For the NHS, Brexit comes at a time when it faces many other major challenges. These include severe financial pressures, rising workload, increased waiting times for both primary care and specialist services, and shortages of health professionals in many key areas (such as in general practice and in emergency departments). The NHS also faces challenges fr…

Can GPs issue private prescriptions to NHS patients?

The NHS prescription charge in England is currently £8.60 per item. At this level, many commonly prescribed drugs will cost less than the prescription charge and so some NHS patients may occasionally ask if they can have a private prescription rather than an NHS prescription.

In the past, some GPs have been advised that they could issue both an NHS FP10 and a private prescription, and let the patient decide which to use. But the British Medical Association's General Practice Committee has obtained legal advice that said under the current primary care contract, GPs in England may not issue a private prescription alongside or as an alternative to an NHS FP10 prescription. In any consultation where a GP needs to issue an FP10, the concurrent issue of a private prescription would be a breach of NHS regulations.

The issuing of a private prescription in such circumstances could also be seen as an attempt to deprive the NHS of the funds it would receive from the prescription charge. Fur…